New Covid strain may be in India already: Experts hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
What if you develop side effects after immunisation? The Government has a plan It is completely normal for people to develop side effects after immunisation. In medical jargon, these side effects are called adverse events. These can be minor , severe , or serious , with only the last category requiring hospitalisation. In fact, vaccination drives that are underway the UK and the US have also reported adverse events, especially in people with allergies, says the writer of this article. None were serious . The top three vaccines that are currently awaiting the government s approval in India are Pfizer and BioNTech, Oxford-AstraZeneca and Bharat Biotech s Covaxin. So far, the adverse events have been minor or severe , and the proportion of such cases has been small.
Ethical challenges of vaccinating people with comorbidities
Updated:
Updated:
December 20, 2020 13:16 IST
Each comorbidity increases vulnerability, but in case of vaccine shortage, multimorbidity should be given first preference
Share Article
AAA
Priority for males? Males are at higher risk, but prioritising males with comorbidities over females will result in worsening gender inequities.
| Photo Credit:
AFP
Each comorbidity increases vulnerability, but in case of vaccine shortage, multimorbidity should be given first preference
(Subscribe to Science For All, our weekly newsletter, where we aim to take the jargon out of science and put the fun in. Click here.)
The operational guidelines for COVID-19 vaccination issued recently by the union health ministry has once again identified the four high-risk groups healthcare workers, frontline workers, persons over 50 years of age, and persons younger than 50 years with comorbidities that would receive COVID vaccine on p
10 million Covid+, but India on recovery road hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
Covid Vaccine Should Not Get Nod When Phase III Trial Is Still On: Virologist
Noted virologist Dr Shahid Jameel talks to Outlook on various aspects of the vaccine development process for Covid-19
Representational Image Od Covid Vaccine Jeevan Prakash Sharma 2020-12-17T10:34:59+05:30 Covid Vaccine Should Not Get Nod When Phase III Trial Is Still On: Virologist outlookindia.com 2020-12-17T11:41:46+05:30
Also read
Dr Shahid Jameel, at present the director of the Trivedi School of Biosciences at Ashoka University, is a well-known virologist. A recipient of the prestigious Shanti Swarup Bhatnagar Prize for science and technology, Dr Jameel talks to Outlook on various aspects of the vaccine development process for Covid-19. Excerpts: